Tarje Onsøien Halvorsen
72825675
Gastrosenteret, Øya
Om
Overlege ved Kreftklinikken med ansvar for behandling av lungekreft. PhD i strålebehandling av lungekreft, og har kombinert stilling ved St. Olavs hospital/NTNU. Involvert i mange kliniske studier og translasjonsprosjekt. Underviser medisinstudenter i klinisk onkologi og er fast foreleser ved en rekke nasjonale spesialistkurs. Hovedfokus for forskningen har vært strålebehandling og småcellet lungekreft med begrenset studie, hvor jeg har bred erfaring fra kliniske multisenterstudier. Involvert i flere translasjonsprosjekt som inkluderer ctDNA, miRNA, AI, radiomics, genomic radiosensitivity og spatial transcriptomics. Hovedutprøver for flere kliniske studier og nasjonal koordinerende utprøver for en global legemiddelstudie. Har veiledet flere PhD både som bi- og hovedveileder.
Utdanning:
- Cand. med.(MD), Universitetet i Oslo, 2003
- PhD i palliativ medisin, NTNU, 2017
- Specialist i onkologi, St. Olavs Hospital, 2019
Nåværende stillinger:
- Overlege Kreftklinikken, St. Olavs hospital
- Førsteamanuensis, IKOM, NTNU
- Postdoc, IKOM, NTNU
Forskningsinteresser:
- Strålebehandling ved small cell lungekreft
- Prognostiske og prediktive biomarkører
- Kunstig intelligens (KI)
- Radiomics
Forskning
Klinisk forskning på lungekreft, både småcellet og ikke-småcellet, i alle stadier. Hovedfokus på strålebehandling av småcellet lungekreft. Fokus randomiserte kontrollerte studier og pasientrettet forskning kombinert med bred translasjonell forskning
Publikasjoner
2024
-
Levin, Nina;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien;
Danielsen, Signe;
Grønberg, Bjørn Henning.
(2024)
Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer.
International Journal of Radiation Oncology, Biology, Physics
Vitenskapelig artikkel
-
Graabak, Gustav;
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien.
(2024)
Effect of FDG PET-CT for Staging and Radiotherapy Planning – A Comparison of Cohorts From Two Randomized Trials of Thoracic Radiotherapy in Limited-Stage SCLC.
JTO Clinical and Research Reports
Vitenskapelig artikkel
-
Taranova, Evgenia;
Aanerud, Marianne;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Jordhøy, Marit Slaaen;
Grønberg, Bjørn Henning.
(2024)
Associations Between Patient-Reported Nutritional Status, Toxicity, and Survival in Limited-Stage SCLC.
JTO Clinical and Research Reports
Vitenskapelig artikkel
2023
-
Taranova, Evgenia;
Grønberg, Bjørn Henning;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Slaaen, Marit;
Aanerud, Marianne.
(2023)
Associations between patient-reported nutritional status, survival, and toxicity among patients with limited stage small-cell lung cancer (LS SCLC) in a randomized trial of high-dose, twice-daily (BID) thoracic radiotherapy (TRT).
Journal of Clinical Oncology
Sammendrag/abstract
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Fløtten, Øystein;
Bjaanæs, Maria Moksnes;
Madebo, Tesfaye;
Schytte, Tine.
(2023)
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).
Journal of Clinical Oncology
Sammendrag/abstract
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien.
(2023)
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).
American Journal of Clinical Oncology
Sammendrag/abstract
-
Killingberg, Kristin Toftaker;
Grønberg, Bjørn Henning;
Jordhøy, Marit Slaaen;
Kirkevold, Øyvind;
Halvorsen, Tarje Onsøien.
(2023)
Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC.
Journal of Thoracic Oncology
Vitenskapelig artikkel
-
Ottestad, Anine Larsen;
Johansen, Håkon;
Halvorsen, Tarje Onsøien;
Dai, Hong Yan;
Wahl, Sissel Gyrid Freim;
Emdal, Elisabeth Fritzke.
(2023)
Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer.
BMC Cancer
Vitenskapelig artikkel
-
Ottestad, Anine Larsen;
Johansen, Håkon;
Halvorsen, Tarje Onsøien;
Dai, Hong Yan;
Wahl, Sissel Gyrid Freim;
Emdal, Elisabeth Fritzke.
(2023)
Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by <sup>18</sup>F-FDG PET/CT in early-stage non-small cell lung cancer (BMC Cancer, (2023), 23, 1, (646), 10.1186/s12885-023-11147-z).
BMC Cancer
Errata
2022
-
Levin, Nina;
Danielsen, Signe;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Redalen, Kathrine Røe;
Grønberg, Bjørn Henning.
(2022)
Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer.
Radiotherapy and Oncology
Sammendrag/abstract
-
Stokke, Kristin;
Halvorsen, Tarje Onsøien;
Grønberg, Bjørn Henning;
Saltvedt, Ingvild;
Jordhøy, Marit Slaaen;
Kirkevold, Øyvind.
(2022)
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC.
Healthcare
Vitenskapelig artikkel
-
Graabak, Gustav;
Grønberg, Bjørn Henning;
Sandvei, Marie Søfteland;
Nilssen, Yngvar;
Halvorsen, Tarje Onsøien.
(2022)
Thoracic Radiotherapy in Limited-Stage SCLC—a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018.
JTO Clinical and Research Reports
Vitenskapelig artikkel
-
Horndalsveen, Henrik;
Alver, Tine Norman;
Dalsgaard, Astrid Marie;
ROGG, LOTTE VICTORIA;
Helbekkmo, Nina;
Grønberg, Bjørn Henning.
(2022)
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT-1 trial.
Molecular Oncology
Vitenskapelig artikkel
-
Ottestad, Anine Larsen;
Emdal, Elisabeth Fritzke;
Grønberg, Bjørn Henning;
Halvorsen, Tarje Onsøien;
Dai, Hong Yan.
(2022)
Fragmentation assessment of FFPE DNA helps in evaluating NGS library complexity and interpretation of NGS results.
Experimental and molecular pathology (Print)
Vitenskapelig artikkel
-
Stokke, Kristin;
Sandvei, Marie Søfteland;
Grønberg, Bjørn Henning;
Jordhøy, Marit Slaaen;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien.
(2022)
Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer.
Clinical Medicine Insights: Oncology
Vitenskapelig artikkel
-
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien;
Fløtten, Øystein;
Brustugun, Odd Terje;
Langer, Seppo W.;
Nyman, Jan.
(2022)
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
Lung Cancer
Vitenskapelig artikkel
2021
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Fløtten, Øystein;
Brustugun, Odd;
HORNSLIEN, KJERSTI;
Madebo, Tesfaye.
(2021)
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
The Lancet Oncology
Vitenskapelig artikkel
-
Wahl, Sissel Gyrid Freim;
Hong, Yan Dai;
Emdal, Elisabeth Fritzke;
Berg, Thomas;
Halvorsen, Tarje Onsøien;
Ottestad, Anine Larsen.
(2021)
The prognostic effect of KRAS mutations in non-small cell lung carcinoma revisited: A norwegian multicentre study.
Cancers
Vitenskapelig artikkel
-
Wahl, Sissel Gyrid Freim;
Hong, Yan Dai;
Emdal, Elisabeth Fritzke;
Ottestad, Anine Larsen;
Dale, Vibeke Grotnes;
Richardsen, Elin.
(2021)
Prognostic value of absolute quantification of mutated KRAS
in circulating tumour DNA in lung adenocarcinoma patients
prior to therapy.
The journal of pathology. Clinical research
Vitenskapelig artikkel
-
Grønberg, Bjørn Henning;
Langer, Seppo W.;
Nyman, Jan;
Halvorsen, Tarje Onsøien.
(2021)
Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer – Authors' reply.
The Lancet Oncology
Brev til redaktøren
-
Ottestad, Anine Larsen;
Hong, Yan Dai;
Halvorsen, Tarje Onsøien;
Emdal, Elisabeth Fritzke;
Wahl, Sissel Gyrid Freim;
Grønberg, Bjørn Henning.
(2021)
Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer.
Cancer Treatment and Research Communications
Vitenskapelig artikkel
2020
-
Sjøgren, Kristina;
Jacobsen, Kristian Aalberg;
Grønberg, Bjørn Henning;
Halvorsen, Tarje Onsøien.
(2020)
Timing of severe toxicity from chemotherapy in patients with lung cancer.
Anticancer Research
Vitenskapelig artikkel
-
Halvorsen, Tarje Onsøien;
Valan, Christine Damgaard;
Jordhøy, Marit Slaaen;
Grønberg, Bjørn Henning.
(2020)
Associations between muscle measures, survival and toxicity in patients with limited disease small cell lung cancer.
Journal of Cachexia, Sarcopenia and Muscle
Vitenskapelig artikkel
-
Valan, Christine Damgaard;
Halvorsen, Tarje Onsøien;
Jordhøy, Marit Slaaen;
Grønberg, Bjørn Henning.
(2020)
Changes in muscle measures during chemoradiotherapy in patients with limited stage small cell lung cancer.
JCSM Clinical Reports
Vitenskapelig artikkel
-
Halvorsen, Tarje Onsøien;
Stokke, Kristin;
Killingberg, Kristin Toftaker;
Raj, Sunil Xavier;
Sørhaug, Sveinung;
Brustugun, Odd Terje.
(2020)
Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC.
Acta Oncologica
Vitenskapelig artikkel
2019
-
Grønberg, Bjørn Henning;
Valan, Christine Damgaard;
Halvorsen, Tarje Onsøien;
Sjøblom, Bjørg;
Jordhøy, Marit Slaaen.
(2019)
Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients.
Journal of Cachexia, Sarcopenia and Muscle
Vitenskapelig artikkel
2018
-
Valan, Christine Damgaard;
Slagsvold, Jens Erik;
Halvorsen, Tarje Onsøien;
Herje, Martin;
Bremnes, Roy M.;
Brunsvig, Paal Fr..
(2018)
Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement.
Anticancer Research
Vitenskapelig artikkel
-
Halvorsen, Tarje Onsøien;
Grønberg, Bjørn Henning.
(2018)
Komorbiditet ved småcellet lungekreft og begrenset utbredelse (LD SCLC).
Best Practice Onkologi/Hematologi
Fagartikkel
2017
-
Krogstad, Hilde;
Brunelli, Cinzia;
Sand, Kari;
Andersen, Eivind;
Garresori, Herish;
Halvorsen, Tarje Onsøien.
(2017)
Development of EirV3: A computer-based tool for patient-reported outcome measures in cancer.
JCO Clinical Cancer Informatics
Vitenskapelig artikkel
Tidsskriftspublikasjoner
-
Levin, Nina;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien;
Danielsen, Signe;
Grønberg, Bjørn Henning.
(2024)
Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer.
International Journal of Radiation Oncology, Biology, Physics
Vitenskapelig artikkel
-
Graabak, Gustav;
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien.
(2024)
Effect of FDG PET-CT for Staging and Radiotherapy Planning – A Comparison of Cohorts From Two Randomized Trials of Thoracic Radiotherapy in Limited-Stage SCLC.
JTO Clinical and Research Reports
Vitenskapelig artikkel
-
Taranova, Evgenia;
Aanerud, Marianne;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Jordhøy, Marit Slaaen;
Grønberg, Bjørn Henning.
(2024)
Associations Between Patient-Reported Nutritional Status, Toxicity, and Survival in Limited-Stage SCLC.
JTO Clinical and Research Reports
Vitenskapelig artikkel
-
Taranova, Evgenia;
Grønberg, Bjørn Henning;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Slaaen, Marit;
Aanerud, Marianne.
(2023)
Associations between patient-reported nutritional status, survival, and toxicity among patients with limited stage small-cell lung cancer (LS SCLC) in a randomized trial of high-dose, twice-daily (BID) thoracic radiotherapy (TRT).
Journal of Clinical Oncology
Sammendrag/abstract
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Fløtten, Øystein;
Bjaanæs, Maria Moksnes;
Madebo, Tesfaye;
Schytte, Tine.
(2023)
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).
Journal of Clinical Oncology
Sammendrag/abstract
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien.
(2023)
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).
American Journal of Clinical Oncology
Sammendrag/abstract
-
Killingberg, Kristin Toftaker;
Grønberg, Bjørn Henning;
Jordhøy, Marit Slaaen;
Kirkevold, Øyvind;
Halvorsen, Tarje Onsøien.
(2023)
Treatment Outcomes of Older Participants in a Randomized Trial Comparing Two Schedules of Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC.
Journal of Thoracic Oncology
Vitenskapelig artikkel
-
Ottestad, Anine Larsen;
Johansen, Håkon;
Halvorsen, Tarje Onsøien;
Dai, Hong Yan;
Wahl, Sissel Gyrid Freim;
Emdal, Elisabeth Fritzke.
(2023)
Associations between detectable circulating tumor DNA and tumor glucose uptake measured by 18F-FDG PET/CT in early-stage non-small cell lung cancer.
BMC Cancer
Vitenskapelig artikkel
-
Ottestad, Anine Larsen;
Johansen, Håkon;
Halvorsen, Tarje Onsøien;
Dai, Hong Yan;
Wahl, Sissel Gyrid Freim;
Emdal, Elisabeth Fritzke.
(2023)
Correction: Associations between detectable circulating tumor DNA and tumor glucose uptake measured by <sup>18</sup>F-FDG PET/CT in early-stage non-small cell lung cancer (BMC Cancer, (2023), 23, 1, (646), 10.1186/s12885-023-11147-z).
BMC Cancer
Errata
-
Levin, Nina;
Danielsen, Signe;
Halvorsen, Tarje Onsøien;
Killingberg, Kristin Toftaker;
Redalen, Kathrine Røe;
Grønberg, Bjørn Henning.
(2022)
Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer.
Radiotherapy and Oncology
Sammendrag/abstract
-
Stokke, Kristin;
Halvorsen, Tarje Onsøien;
Grønberg, Bjørn Henning;
Saltvedt, Ingvild;
Jordhøy, Marit Slaaen;
Kirkevold, Øyvind.
(2022)
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC.
Healthcare
Vitenskapelig artikkel
-
Graabak, Gustav;
Grønberg, Bjørn Henning;
Sandvei, Marie Søfteland;
Nilssen, Yngvar;
Halvorsen, Tarje Onsøien.
(2022)
Thoracic Radiotherapy in Limited-Stage SCLC—a Population-Based Study of Patterns of Care in Norway From 2000 Until 2018.
JTO Clinical and Research Reports
Vitenskapelig artikkel
-
Horndalsveen, Henrik;
Alver, Tine Norman;
Dalsgaard, Astrid Marie;
ROGG, LOTTE VICTORIA;
Helbekkmo, Nina;
Grønberg, Bjørn Henning.
(2022)
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses—the ComIT-1 trial.
Molecular Oncology
Vitenskapelig artikkel
-
Ottestad, Anine Larsen;
Emdal, Elisabeth Fritzke;
Grønberg, Bjørn Henning;
Halvorsen, Tarje Onsøien;
Dai, Hong Yan.
(2022)
Fragmentation assessment of FFPE DNA helps in evaluating NGS library complexity and interpretation of NGS results.
Experimental and molecular pathology (Print)
Vitenskapelig artikkel
-
Stokke, Kristin;
Sandvei, Marie Søfteland;
Grønberg, Bjørn Henning;
Jordhøy, Marit Slaaen;
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien.
(2022)
Prognostic Value of Post First-Line Chemotherapy Glasgow Prognostic Score in Advanced Non-Small Cell Lung Cancer.
Clinical Medicine Insights: Oncology
Vitenskapelig artikkel
-
Killingberg, Kristin Toftaker;
Halvorsen, Tarje Onsøien;
Fløtten, Øystein;
Brustugun, Odd Terje;
Langer, Seppo W.;
Nyman, Jan.
(2022)
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer.
Lung Cancer
Vitenskapelig artikkel
-
Grønberg, Bjørn Henning;
Killingberg, Kristin Toftaker;
Fløtten, Øystein;
Brustugun, Odd;
HORNSLIEN, KJERSTI;
Madebo, Tesfaye.
(2021)
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial.
The Lancet Oncology
Vitenskapelig artikkel
-
Wahl, Sissel Gyrid Freim;
Hong, Yan Dai;
Emdal, Elisabeth Fritzke;
Berg, Thomas;
Halvorsen, Tarje Onsøien;
Ottestad, Anine Larsen.
(2021)
The prognostic effect of KRAS mutations in non-small cell lung carcinoma revisited: A norwegian multicentre study.
Cancers
Vitenskapelig artikkel
-
Wahl, Sissel Gyrid Freim;
Hong, Yan Dai;
Emdal, Elisabeth Fritzke;
Ottestad, Anine Larsen;
Dale, Vibeke Grotnes;
Richardsen, Elin.
(2021)
Prognostic value of absolute quantification of mutated KRAS
in circulating tumour DNA in lung adenocarcinoma patients
prior to therapy.
The journal of pathology. Clinical research
Vitenskapelig artikkel
-
Grønberg, Bjørn Henning;
Langer, Seppo W.;
Nyman, Jan;
Halvorsen, Tarje Onsøien.
(2021)
Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer – Authors' reply.
The Lancet Oncology
Brev til redaktøren
-
Ottestad, Anine Larsen;
Hong, Yan Dai;
Halvorsen, Tarje Onsøien;
Emdal, Elisabeth Fritzke;
Wahl, Sissel Gyrid Freim;
Grønberg, Bjørn Henning.
(2021)
Associations between tumor mutations in cfDNA and survival in non-small cell lung cancer.
Cancer Treatment and Research Communications
Vitenskapelig artikkel
-
Sjøgren, Kristina;
Jacobsen, Kristian Aalberg;
Grønberg, Bjørn Henning;
Halvorsen, Tarje Onsøien.
(2020)
Timing of severe toxicity from chemotherapy in patients with lung cancer.
Anticancer Research
Vitenskapelig artikkel
-
Halvorsen, Tarje Onsøien;
Valan, Christine Damgaard;
Jordhøy, Marit Slaaen;
Grønberg, Bjørn Henning.
(2020)
Associations between muscle measures, survival and toxicity in patients with limited disease small cell lung cancer.
Journal of Cachexia, Sarcopenia and Muscle
Vitenskapelig artikkel
-
Valan, Christine Damgaard;
Halvorsen, Tarje Onsøien;
Jordhøy, Marit Slaaen;
Grønberg, Bjørn Henning.
(2020)
Changes in muscle measures during chemoradiotherapy in patients with limited stage small cell lung cancer.
JCSM Clinical Reports
Vitenskapelig artikkel
-
Halvorsen, Tarje Onsøien;
Stokke, Kristin;
Killingberg, Kristin Toftaker;
Raj, Sunil Xavier;
Sørhaug, Sveinung;
Brustugun, Odd Terje.
(2020)
Randomized phase III trial comparing switch-maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC.
Acta Oncologica
Vitenskapelig artikkel
-
Grønberg, Bjørn Henning;
Valan, Christine Damgaard;
Halvorsen, Tarje Onsøien;
Sjøblom, Bjørg;
Jordhøy, Marit Slaaen.
(2019)
Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients.
Journal of Cachexia, Sarcopenia and Muscle
Vitenskapelig artikkel
-
Valan, Christine Damgaard;
Slagsvold, Jens Erik;
Halvorsen, Tarje Onsøien;
Herje, Martin;
Bremnes, Roy M.;
Brunsvig, Paal Fr..
(2018)
Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement.
Anticancer Research
Vitenskapelig artikkel
-
Halvorsen, Tarje Onsøien;
Grønberg, Bjørn Henning.
(2018)
Komorbiditet ved småcellet lungekreft og begrenset utbredelse (LD SCLC).
Best Practice Onkologi/Hematologi
Fagartikkel
-
Krogstad, Hilde;
Brunelli, Cinzia;
Sand, Kari;
Andersen, Eivind;
Garresori, Herish;
Halvorsen, Tarje Onsøien.
(2017)
Development of EirV3: A computer-based tool for patient-reported outcome measures in cancer.
JCO Clinical Cancer Informatics
Vitenskapelig artikkel
Undervisning
Underviser i PKU (klinisk onkologi) og PBL på tredjeåret for medisinstudenter ved NTNU
Foreleser på nasjonal spesialistkurs i indremedisin og onkologi
Foreleser ved masterkurs i molekylærbiologi
Veiledning
Har vært hovedveileder for 3 fullførte PhD, i tillegg til bi-veileder for 2. Har veiledet 6 medisinstudenter.
Formidling
2023
-
Faglig foredragLevin, Nina; Danielsen, Signe; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Redalen, Kathrine Røe; Grønberg, Bjørn Henning. (2023) Dose-response of acute esophagitis for limited stage small cell lung cancer - Data from a randomized phase II trial. Acta Oncologica BiGART , Aarhus, Danmark 2023-06-20 - 2023-06-21
-
Faglig foredragGrønberg, Bjørn Henning; Killingberg, Kristin Toftaker; Halvorsen, Tarje Onsøien. (2023) Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC). ASCO ASCO 2023 , Chicago 2023-06-02 - 2023-06-06
-
PosterOttestad, Anine Larsen; Johansen, Håkon; Halvorsen, Tarje Onsøien; Dai, Hong Yan; Wahl, Sissel Gyrid Freim; Emdal, Elisabeth Fritzke. (2023) High tumor metabolic activity is associated with circulating tumor DNA detection in early-stage lung cancer patients. 13th International Symposium on Minimal Residual Cancer 2023-05-02 - 2023-05-04
2022
-
Faglig foredragLevin, Nina; Danielsen, Signe; Halvorsen, Tarje Onsøien; Killingberg, Kristin Toftaker; Redalen, Kathrine Røe; Grønberg, Bjørn Henning. (2022) Comparing target volumes in a randomized trial of high-dose radiotherapy in small cell lung cancer. European Society for Radiotherapy and Oncology (ESTRO) ESTRO 2022 , København 2022-05-06 - 2022-05-10
-
Vitenskapelig foredragOttestad, Anine Larsen; Johansen, Håkon; Halvorsen, Tarje Onsøien; Sandvei, Marie Søfteland; Grønberg, Bjørn Henning. (2022) Association between ctDNA detection and tumor metabolic activity measured by PET/CT . Clinical implementation of liquid biopsy in the treatment of lung cancer 2022-11-10 - 2022-11-10
2019
-
PosterStokke, Kristin; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Sørhaug, Sveinung; Madebo, Tesfaye; Raj, Sunil Xavier. (2019) Randomized phase III trial comparing maintenance pemetrexed with observation followed by pemetrexed at progression in advanced NSCLC. Verdenskonferansen for lungekreft, WCLC , Barcelona 2019-09-07 - 2019-09-10
-
PosterWahl, Sissel Gyrid Freim; Dai, Hong Yan; Emdal, Elisabeth Fritzke; Ottestad, Anine Larsen; Richardsen, Elin; Halvorsen, Tarje Onsøien. (2019) Prognostic value of mutated KRAS in circulating tumor DNA prior to therapy in patients with lung cancer. IASLC World Conference on Lung Cancer 2019 , Barcelona 2019-09-07 - 2019-09-10
2016
-
Faglig foredragHalvorsen, Tarje Onsøien. (2016) Thorakal strålebehandling ved småcellet lungekreft begrenset utbredelse. Norsk Onkologisk Forening Onkologisk Forum 2016 , Trondheim 2016-11-16 - 2016-11-17
2015
-
PosterGrønberg, Bjørn Henning; Sundstrøm, Stein Harald; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf. (2015) Association between comorbidity, treatment toxicity and overall survival in limited disease small-cell lung cancer. International Association for the study of Lung Cancer 16TH WORLD CONFERENCE ON LUNG CANCER , Denver, Colorado 2015-09-06 - 2015-09-09
-
PosterValan, Christine Damgaard; Halvorsen, Tarje Onsøien; Levin, Nina; Bremnes, Roy M.; Brunsvig, Paal Fr.; Brustugun, Odd Terje. (2015) Survival of patients with N3 lymph node disease in a cohort with limited disease small-cell lung cancer receiving concurrent chemoradiotherapy. International Association for the study of Lung Cancer 16TH WORLD CONFERENCE ON LUNG CANCER , Denver, Colorado 2015-09-06 - 2015-09-09
-
Vitenskapelig foredragHalvorsen, Tarje Onsøien. (2015) Småcellet lungekreft med begrenset utbredelse. Skal pasienter med komorbiditet motta standard behandling ?. Forskningsavdelingen i Helse Nord-Trøndelag Regional forskningskonferanse 2015 , Stjørdal 2015-06-09 - 2015-06-10
-
Vitenskapelig foredragHalvorsen, Tarje Onsøien. (2015) EIR – et klinisk verktøy for symptomkartlegging og beslutningsstøtte . HEMIT Hemit-konferansen 2015 – IKT for liv og helse , Trondheim 2015-03-18 - 2015-03-18
2014
-
Vitenskapelig foredragValan, Christine Damgaard; Halvorsen, Tarje Onsøien; Balstad, Trude Rakel; Sjøblom, Bjørg; Jordhøy, Marit; Solheim, Tora Skeidsvoll. (2014) The prognostic value of comorbidity and body muscle mass in patient with advanced non-small-cell lung cancer. European Association of Palliative Care 4th International Seminar of the PRC and EAPC RN , Amsterdam 2014-10-16 - 2014-10-17
2012
-
PosterGrønberg, Bjørn Henning; Halvorsen, Tarje Onsøien; Fløtten, Øystein; Brustugun, Odd Terje; Brunsvig, Paal Fr.; Aasebø, Ulf. (2012) Phase II Trial Comparing Two Schedules of Thoracic Radiotherapy in Limited Disease Small-Cell Lung Cancer. American Society of Clinical Oncology ASCO Annual Meeting 2012 , Chicago 2012-06-01 - 2012-06-05